Do secondary mitochondrial DNA defects cause retinal ganglion cell death in dominant optic atrophy?
Do secondary mitochondrial DNA defects cause retinal ganglion cell death in dominant optic atrophy?
批准号:
G0701386/1
负责人:
Patrick Yu Wai Man
金额:
$25.14万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dominant optic atrophy (DOA) is one of the commonest form of inherited blindness and it results in significant visual disability. DOA is caused by irreversible damage to the optic nerve, which connects the eye to the vision centres within the brain. It is a specialised cable made up of about 2 million, highly specialised cells known as retinal ganglion cells (RGCs). In 60-70% of cases, DOA is due to a mutation in the OPA1 gene but we still do not know how this genetic defect leads to disease and why only RGCs are affected. Our preliminary findings in one large family with DOA indicate that the OPA1 mutation compromises the normal function of mitochondria. Mitochondria are essential components of all human cells and they are responsible for energy production. If insufficient energy is produced, cells cannot function properly and die. To test my hypothesis further, I will analyse blood and muscle biopsies from additional families with DOA for evidence of mitochondrial dysfunction. I will also analyse RGCs from a mouse model of DOA and determine if they contain high levels of mitochondrial DNA abnormalities. Finally, I will try to identify the gene(s) responsible for DOA in those families who not carry an OPA1 mutation. RGCs are affected in other eye conditions like glaucoma and a better understanding of their selective vulnerability will help us develop more effective treatment strategies for these blinding diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
What disease mechanisms contribute to multisystem tissue involvement in dominant optic atrophy due to OPA1 mutations?
-
批准号:G1002570/1
-
项目类别:Fellowship
-
资助金额:$114.44万
-
财政年份:2012
-
负责人:Patrick Yu Wai Man
-
依托单位:
海外基金